FACTOR | CASE FATALITY WITH FACTOR | CASE FATALITY WITHOUT FACTOR | RELATIVE RISK (95% CI) | P-VALUE |
---|---|---|---|---|
Adequate by t = 0 | 1/11 (9%) | 15/68 (22%) | 0.41 (0.06-2.81) | NS |
Adequate by t = 8 hours | 6/22 (27%) | 10/57(18%) | 1.55 (0.64-3.76) | 0.09 |
Adequate by t = 24 hours | 7/28 (25%) | 9/51 (18%) | 1.42 (0.59-3.39) | 0.10 |
Adequate by t = 48 hours | 9/42 (21%) | 7/37 (18%) | 1.13 (0.47-2.74) | NS |
Adequate at t > 48 hours | 3/33 (9%) | 13/46 (28%) | 0.32 (0.10-1.04) | NS |
Never received adequate therapy | 4/4 (100%) | 12/75 (16%) | 6.25 (3.72-10.5) | 0.01 |
First Adequate Antibiotic Choice | Â | Â | Â | Â |
Beta-lactam/Beta-lactamase inhibitor combination | 6/28 (21%) | 10/51 (20%) | 1.09 (0.44-2.69) | NS |
Carbapenem | 4/30 (13%) | 12/49 (24%) | 0.54 (0.19-1.53) | NS |
Fluoroquinolone | 1/4 (25%) | 15/75 (20%) | 1.25 (0.22-7.24) | NS |
Aminoglycoside | 1/10 (10%) | 15/69 (22%) | 0.46 (0.07-3.11) | NS |
Sulfa | 1/3 (33%) | 15/76 (20%) | 1.69 (0.32-8.91) | NS |